glp-1 market news today North America Glucagon-Like Peptide-1 (GLP-1) Agonist obesity drug news today glp-1

Portion into appropriately sized glass containers

Learn about the mechanism of action of RYBELSUS (semaglutide) for your adult patients with type 2 diabetes

Through its unique mechanism of action as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, as well as its impressive results in clinical trials, tirzepatide has the potential to completely transform the current approach to treating obesity

Please confirm your status as a healthcare professional to access the content.

Stay tuned next week on 23rd December for the full 2026 Health Populi TrendCast with a focus on digital health trends we anticipate will set the stage for CES 2026

Ingredients, research, pricing, MLM structure, and how it compares to prescription GLP-1 medications.